| 1 |
Kim S, Jung S, Kim D-S. The opinion of experts and stakeholder on introduction of orphan or anticancer drugs funding program. Korean J Clin Pharm 2020;30(3):177-84./
|
|
| 2 |
Yoon SM, Lee SW, Chang JE, Lee YS, Rhew KY. The prescribing patterns of antipsychotic drugs and antiparkinsonian drugs in elderly patients with dementia. Korean J Clin Pharm 2020;30(2):81-6./
|
|
| 3 |
Kim M-S, You S-H, Park HM, et al. Patterns of spontaneous adverse events reporting on human papillomavirus vaccines according to the applicability of Brighton Collaboration Criteria in Korea from 2008 to 2017. Korean J Clin Pharm 2020;30(1):19-30./
|
|
| 4 |
Gohye Eoum, Yoonsook Cho, Sandy Jeong Rhie. Evaluation of nivolumab use and factors related to treatment outcomes in a cancer center of a top tier general hospital. Korean J Clin Pharm 2018;28(2):88-94./
|
|
| 5 |
Kim E, Kim Y. Review of programs for improving patient's access to medicines. Korean J Clin Pharm 2018;28(1):40-50./
|
|
| 6 |
Chun PS and Sin HY. Long term assessment of outcome of essential competencies in CPPE at tertiary and secondary hospitals located in Seoul and Gyeonggi-do: College of pharmacy students' evaluation from 2014 to 2018. Korean J Clin Pharm 2018;28(4):300-7./
|
|